Wednesday, April 13, 2016

Global Female Fertility and Pregnancy Rapid Test Market to Witness 4.5% CAGR During 2016 – 2022: P&S Market … – PR Newswire (press release)

NEW YORK, April 13, 2016 /PRNewswire/ —

The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% throughout the period 2016 – 2022. The global market is increasing, because of growing female geriatric population and increasing incidence of uterine malformations. In addition, the growing female infertility cases, increasing cases along with abnormal uterine bleeding and growing necessity for straightforward to usage at residence diagnostic equipments are encouraging the growth of the global female fertility and pregnancy rapid test market.

     (Logo: http://ift.tt/1U93Eml )

Explore Complete Report on Female fertility and pregnancy rapid test Market at: http://ift.tt/1SzYE71

The increasing aging population is propelling the growth of the global female fertility and pregnancy rapid test market, as the elderly population is much more susceptible to gynaecological problems, such as abnormal uterine bleeding, fibroids, and polyps, as compared to adults, which is fuelling the necessity  female fertility and pregnancy rapid tests. Aging leads to adjustments in bodily hormones best to irregular menses, which contribute to the necessity for hormonal tests, thus driving the growth of the market.

Infertility can easily be a result of inappropriate diet, bad lifestyle, consumption of alcohol, tobacco, lack of proper sleep, hormonal imbalance resulting in inability to conceive. For instance as reported by American Pregnancy Association (APA), infertility affects about 1 from every 6 couples and female infertility accounts for concerning one-3rd of every one of infertility cases. Furthermore, as reported by CDC, concerning 12% of women in between the age group 15-44 years of age in the U.S. have actually difficulty in obtaining pregnant or carrying a pregnancy.

Request for Report Sample: http://ift.tt/260emm4

The advantageous features possessed by these at residence pregnancy and fertility rapid test attract the patients about the globe to go with such straightforward to usage equipments rather than choosing a lab based test. At residence fertility and pregnancy rapid test are time saving, comparatively economical, assists keep privacy and can easily be used by the females at the comfort of their home; thus, generating a higher necessity for at residence diagnostic equipments fuelling the growth of the global female fertility and pregnancy rapid test market.

Browse Related Reports: http://ift.tt/1MwHrNU

However, the availability of alternative diagnostic test such as blood test and reagent based laboratory test are inhibiting the growth of the global female fertility and pregnancy rapid test market. In addition, the higher expense of midstreams, in comparison to strips/dipsticks and cassettes/cards make them much less affordable by the patient pool is further restraining the growth of the market. The Asian market is expected to witness the fastest growth throughout the period 2016 – 2022.

The crucial companies operating in the global female fertility and pregnancy rapid test market consist of Alere Inc., Atlas Medical, Diagnostic Automation/Cortez Diagnostics Inc., BioMerieux SA, SA Scientific, Church & Dwight Co., Inc.., Nantong Egens Biotechnology Co. Ltd., and Gemc Technology Group Co., Ltd.

GLOBAL FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET SEGMENTATION 

By Type of Test 

  • Luteinizing hormone (LH) Female fertility rapid tests
  • Follicle Stimulating Hormone (FSH) Female fertility rapid tests
  • Human Chorionic Gonadotropin (HCG) Pregnancy rapid tests

By Product 

  • Strips/Dipsticks
    • Luteinizing hormone (LH)
    • Follicle Stimulating Hormone (FSH)
    • Human Chorionic Gonadotropin (HCG)
  • Cards/Cassettes
    • Luteinizing hormone (LH)
    • Follicle Stimulating Hormone (FSH)
    • Human Chorionic Gonadotropin (HCG)
  • Midstreams
    • Luteinizing hormone (LH)
    • Follicle Stimulating Hormone (FSH)
    • Human Chorionic Gonadotropin (HCG)

By Geography 

  • North America– The U.S., Canada, and remainder of North America
  • Europe– The U.K, Germany, France, Italy, Spain, and remainder of Europe
  • AsiaChina, Japan, India, and remainder of Asia
  • Rest of the globe (RoW)- Brazil, Australia, and Others

Browse Various other Reports BY P&S Market Research 

Global Neurostimulation equipments Market- http://ift.tt/260eoKI

Global Self-Monitoring Blood Glucose (SMBG) equipments Market – http://ift.tt/1SzYEni

Global Hysteroscope Market – http://ift.tt/260eoKL

About P&S Market Research 

P&S Market Research is a market research company, which supplies market research and consulting programs for various geographies about the globe. We give market research reports, industry forecasting reports, firm intelligence, and research based consulting programs across various industry/firm verticals.

As among the leading growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient along with firm intelligence and market analysis, through their interaction along with best companies of the concerned domain. We guidance our clients along with B2B market research and aid them in determining various windows of opportunity, and framing informed and customized firm expansion strategies in various regions.

Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
Email: enquiry@psmarketresearch.com

Web: http://ift.tt/21a9GtW

SOURCE P&S Market Research